Evidence map›Paper›PMID 23778908›Full record

ArticleAnnals of internal medicine2013

A historic moment for open science: the Yale University Open Data Access project and medtronic.

Harlan M Krumholz, Joseph S Ross, Cary P Gross, Ezekiel J Emanuel, Beth Hodshon, Jessica D Ritchie, Jeffrey B Low, Richard Lehman

Abstract readEditorialComment
In one paragraph

Article in Annals of internal medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Enzyme replacement and substrate reduction therapy for Gaucher disease.The Cochrane database of systematic reviews · 2015
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Data Sharing and Embedded Research.Annals of internal medicine · 2017
    Article
  16. Review
  17. Is Open Science the Future of Drug Development?The Yale journal of biology and medicine · 2017
    Review
  18. Intrathecal Drug Delivery Systems (IDDS): The Implantable Systems Performance Registry (ISPR).Neuromodulation : journal of the International Neuromodulation Society · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Harlan M Krumholz
Joseph S Ross
Cary P Gross
Ezekiel J Emanuel
Beth Hodshon
Jessica D Ritchie
Jeffrey B Low
Richard Lehman

Funding

Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
Impact of Publicity Reporting Hospital Outcome Measures for Older AdultsK08AG032886 · NIA · YALE UNIVERSITY · PI ROSS, JOSEPH SOLOMON · 2008 to 2012
$738k
NHLBI NIH HHS 1U01HL105270-03NHLBI NIH HHS U01 HL105270NIA NIH HHS K08 AG032886
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Conflict of InterestDrug IndustryPublication BiasSpinal FusionBone Morphogenetic Protein 2HumansIntervertebral Disc DegenerationRecombinant ProteinsTransforming Growth Factor betaBone Morphogenetic Protein 2recombinant human bone morphogenetic protein-2Recombinant ProteinsTransforming Growth Factor beta

Identifiers

PMID23778908
PMCPMC5459387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.